Rockwell Medical, Inc. Stock Analysis & AI Score
Rockwell Medical, Inc. (RMTI) has an ST Score of 53.8 (B-), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Buy with a $20.00 price target (+133.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Rockwell Medical, Inc. (RMTI) has an ST Score of 53.8 (B-), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Buy with a $20.00 price target (+133.4% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD+
All factor grades
- ForecastA
- GrowthB
- Financial StrengthB-
- ValuationC+
- MomentumC
- ProfitabilityD+
- Piotroski5/9
Contact
RMTI stock: frequently asked questions
What is RMTI's ST Score?
Rockwell Medical, Inc. (RMTI) has an ST Score of 53.8 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RMTI a buy, hold, or sell?
Analysts rate RMTI a Buy, with a price target of $20.00 (+133.4% vs the current price). Our ST Score grades it B- (53.8/100). The ST Score is a data-driven signal, not a recommendation.
What are RMTI's factor grades?
Valuation C+, Profitability D+, Financial Strength B-, Momentum C, Growth B, Forecast A.
What is RMTI's valuation grade?
Rockwell Medical, Inc. (RMTI) earns a valuation grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RMTI's growth grade?
Rockwell Medical, Inc. (RMTI) earns a growth grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RMTI's profitability grade?
Rockwell Medical, Inc. (RMTI) earns a profitability grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RMTI's financial strength grade?
Rockwell Medical, Inc. (RMTI) earns a financial strength grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for RMTI?
The average analyst price target for Rockwell Medical, Inc. (RMTI) is $20.00 from 16 analysts, which is +133.4% versus the recent price of $8.57.
What is RMTI's Piotroski score?
Rockwell Medical, Inc. (RMTI) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.